• Repurposing Natural Compounds Against SARS-CoV-2 Main Protea

  2026-04-24

  This study systematically evaluates natural vitamin-derived compounds as inhibitors of the SARS-CoV-2 main protease (3CLpro) and spike protein RBD, using in silico docking and molecular dynamics. The findings highlight several safe, affordable molecules capable of targeting viral entry and replication, offering a promising foundation for future antiviral therapeutics research.

• Quercetin Modulates Hippo Pathway to Protect Against Catarac

  2026-04-23

  This study provides mechanistic evidence that quercetin alleviates cataract formation by suppressing the Hippo signaling pathway, thereby reducing lens epithelial cell apoptosis and oxidative damage. These findings highlight a potential pharmacological strategy for cataract prevention targeting Hippo pathway modulation.

• Probenecid (4-(dipropylsulfamoyl)benzoic acid): Precision Mo

  2026-04-23

  Explore the unique biochemical and translational properties of Probenecid in modulating multidrug resistance and neuroprotection. This in-depth analysis reveals how 4-(dipropylsulfamoyl)benzoic acid is redefining assay design and immunometabolic applications.

• Baicalin Restores Visual Cortex Plasticity in Adult Amblyopi

  2026-04-22

  This study demonstrates that Baicalin, a flavone glycoside from Scutellaria baicalensis, reactivates ocular dominance plasticity and restores vision in adult mice with amblyopia. The findings suggest a novel pharmacological strategy for overcoming critical period closure and treating adult visual impairment.

• Pazopanib (GW-786034): Optimizing Cancer Research Assays

  2026-04-22

  Pazopanib (GW-786034) stands out as a potent, multi-targeted RTK inhibitor, streamlining workflows for angiogenesis inhibition and tumor growth studies. This guide translates recent high-impact findings into practical protocols, troubleshooting tips, and advanced applications for maximizing reproducibility and translational value.

• Chlorpromazine HCl: Advanced Dopamine Antagonism in Endocyto

  2026-04-21

  Explore the multifaceted role of Chlorpromazine HCl as a dopamine receptor antagonist in cutting-edge neuropharmacology and cell entry pathway research. This article uniquely integrates mechanistic insights with advanced experimental protocols, providing researchers with evidence-backed strategies for assay optimization.

• Cytarabine (AraC): Workflow Enhancements in Leukemia Researc

  2026-04-21

  Unlock targeted apoptosis induction and resistance management in leukemia models with Cytarabine (AraC). This guide details optimized protocols, troubleshooting strategies, and advanced applications that position APExBIO's Cytarabine as the gold standard for high-fidelity cell death research.

• CerS6-Driven Ceramide and Mitochondrial Injury in Liver Stre

  2026-04-20

  Liu et al. (2024) elucidate how restraint stress disrupts ceramide metabolism in rat liver, implicating CerS6-derived C16:0 ceramide in mitochondrial injury via the AMPK/p38 MAPK pathway. These findings clarify a molecular axis for stress-induced hepatocyte damage and offer mechanistic foundations for improved signaling research.

• Doxorubicin: Precision Chemotherapeutic for Cancer Research

  2026-04-20

  Doxorubicin (Adriamycin) remains foundational for apoptosis induction and DNA damage modeling in cancer research. This guide details practical workflows, troubleshooting strategies, and novel insights from recent lipidomic studies that extend Doxorubicin’s utility against drug-resistant cancer cell states.

• Chicken GSDME Drives Pyroptosis in Response to RNA Virus Inf

  2026-04-19

  This study identifies chicken GSDME as the principal effector of pyroptosis following RNA virus infection, a process previously unclear in avian species lacking GSDMD. Through mechanistic dissection, the authors reveal a caspase-3/7-dependent pathway for GSDME cleavage, providing a new framework for understanding host response and cell death in chickens.

• AI-Driven Discovery of Senolytics: Insights from Machine Lea

  2026-04-18

  The referenced study demonstrates a machine learning approach for identifying novel senolytic compounds capable of selectively eliminating senescent cells. This work significantly reduces screening costs and broadens the pipeline for potential interventions in cancer, aging, and related diseases.

• Applied Workflows Using Recombinant Mouse Sonic Hedgehog (SH

  2026-04-17

  Harness the precision and reproducibility of Recombinant Mouse Sonic Hedgehog (SHH) protein for developmental biology research. This guide unpacks validated experimental setups, advanced use cases in limb and urogenital patterning, and troubleshooting tactics, all grounded in comparative studies and APExBIO’s rigorous product specifications.

• Topotecan as a Topoisomerase I Inhibitor: Pharmacology and C

  2026-04-16

  This review dissects the pharmacological innovation and clinical experiences with topotecan, a water-soluble, camptothecin-derived topoisomerase I inhibitor. Its unique mechanism, pharmacokinetics, and antitumor activity are contrasted with alkylating agents, highlighting evolving therapeutic strategies in oncology.

• G007-LK Tankyrase 1/2 Inhibitor: Advanced Workflows in Cance

  2026-04-15

  G007-LK, a highly selective tankyrase 1/2 inhibitor from APExBIO, empowers researchers to modulate Wnt/β-catenin and Hippo signaling with unmatched precision. This guide delivers actionable protocols, troubleshooting advice, and real-world use cases for APC mutation colorectal cancer and hepatocellular carcinoma models.

• Intranasal Epinephrine in Dogs: Pharmacokinetics and Cardiac

  2026-04-14

  This article examines a pivotal study investigating the pharmacokinetic profile and cardiovascular effects of intranasal versus intramuscular epinephrine in canine models. The findings highlight the potential of intranasal delivery for rapid systemic exposure with a favorable cardiac safety profile, informing future translational research and emergency treatment strategies.

443 records 20/30 page Previous Next First page 上5页 1617181920 下5页 Last page